H7N9 早诊早治专家共识发布

2017-03-09 佚名 健康报

通过分析总结近期 H7N9 医疗救治情况,国家卫生计生委日前在网站上发布《人感染 H7N9 禽流感早诊早治专家共识》,强调诊断过程中对可疑 H7N9 病例要尽可能采集下呼吸道标本;对疑似或确诊的 H7N9 病例以及出现发热伴呼吸道症状、具备重症危险因素的患者,在发病 48 小时内尽早应用抗流感病毒药物,不必等待病原学检测结果。



通过分析总结近期 H7N9 医疗救治情况,国家卫生计生委日前在网站上发布《人感染 H7N9 禽流感早诊早治专家共识》,强调诊断过程中对可疑 H7N9 病例要尽可能采集下呼吸道标本;对疑似或确诊的 H7N9 病例以及出现发热伴呼吸道症状、具备重症危险因素的患者,在发病 48 小时内尽早应用抗流感病毒药物,不必等待病原学检测结果。

《专家共识》指出,在早期诊断中,对于发热伴呼吸道症状(咳嗽和 / 或咽痛)患者,需详细询问其流行病学史。对可疑 H7N9 病例要及时规范采集呼吸道标本进行病原学及相关检测,宜首选核酸检测,尽可能采集下呼吸道标本。对疑似或确诊的 H7N9 病例以及流感流行季节出现发热伴呼吸道症状、具备重症危险因素的患者,要在发病 48 小时内尽早应用抗流感病毒药物。如症状无改善或持续恶化,对发病时间已超过 48 小时的患者,也要进行抗流感病毒治疗。在抗流感病毒药物选择上,一是首选神经氨酸酶抑制剂,如奥司他韦、帕拉米韦和扎那米韦;二是重症病例以及有重症危险因素、无法经胃肠给药或胃肠功能减弱的患者,建议使用帕拉米韦注射液。

《专家共识》指出,对于疑似或确诊的 H7N9 病例以及流感流行季节出现发热伴呼吸道症状、具备重症危险因素的患者,不具备诊疗能力的医疗机构要给予必要干预并及时转诊。对 H7N9 重症病例或有重症高危因素的病例要尽快转至定点医院进行救治,不具备转诊条件的,要及时向上级卫生计生行政部门报告并妥善处置。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1844711, encodeId=46931844e114b, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Fri Jul 07 18:57:00 CST 2017, time=2017-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477526, encodeId=1b5814e752665, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Fri Mar 10 23:57:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591212, encodeId=3f3215912121e, content=<a href='/topic/show?id=fcbf5950953' target=_blank style='color:#2F92EE;'>#早诊早治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59509, encryptionId=fcbf5950953, topicName=早诊早治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b90817925105, createdName=zsyan, createdTime=Fri Mar 10 23:57:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178809, encodeId=55521e880970, content=有意思,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Fri Mar 10 07:46:21 CST 2017, time=2017-03-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1844711, encodeId=46931844e114b, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Fri Jul 07 18:57:00 CST 2017, time=2017-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477526, encodeId=1b5814e752665, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Fri Mar 10 23:57:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591212, encodeId=3f3215912121e, content=<a href='/topic/show?id=fcbf5950953' target=_blank style='color:#2F92EE;'>#早诊早治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59509, encryptionId=fcbf5950953, topicName=早诊早治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b90817925105, createdName=zsyan, createdTime=Fri Mar 10 23:57:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178809, encodeId=55521e880970, content=有意思,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Fri Mar 10 07:46:21 CST 2017, time=2017-03-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1844711, encodeId=46931844e114b, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Fri Jul 07 18:57:00 CST 2017, time=2017-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477526, encodeId=1b5814e752665, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Fri Mar 10 23:57:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591212, encodeId=3f3215912121e, content=<a href='/topic/show?id=fcbf5950953' target=_blank style='color:#2F92EE;'>#早诊早治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59509, encryptionId=fcbf5950953, topicName=早诊早治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b90817925105, createdName=zsyan, createdTime=Fri Mar 10 23:57:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178809, encodeId=55521e880970, content=有意思,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Fri Mar 10 07:46:21 CST 2017, time=2017-03-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1844711, encodeId=46931844e114b, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Fri Jul 07 18:57:00 CST 2017, time=2017-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1477526, encodeId=1b5814e752665, content=<a href='/topic/show?id=9f7d8411fc' target=_blank style='color:#2F92EE;'>#H7N9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8411, encryptionId=9f7d8411fc, topicName=H7N9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1f27379114, createdName=ms117281293605716, createdTime=Fri Mar 10 23:57:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591212, encodeId=3f3215912121e, content=<a href='/topic/show?id=fcbf5950953' target=_blank style='color:#2F92EE;'>#早诊早治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59509, encryptionId=fcbf5950953, topicName=早诊早治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b90817925105, createdName=zsyan, createdTime=Fri Mar 10 23:57:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178809, encodeId=55521e880970, content=有意思,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ce1618316, createdName=stupidox, createdTime=Fri Mar 10 07:46:21 CST 2017, time=2017-03-10, status=1, ipAttribution=)]
    2017-03-10 stupidox

    有意思,学习了

    0

相关资讯

H7N9疑似病例应尽早抗病毒治疗

2月20日,国家卫生计生委办公厅发出关于加强H7N9医疗救治工作的通知,要求加强病例筛查和早期诊断,符合情况的病例尽早实施抗流感病毒治疗。

世卫专家:H7N9禽流感病毒可持续性人际传播风险低

世界卫生组织“全球流感项目”负责人张文庆1日在日内瓦通报中国H7N9禽流感疫情的最新情况时指出,本轮疫情中发现的H7N9病毒出现了新特征,但总体来说病毒可持续性人际传播风险低。

全国11天累计出现7例H7N9死亡病例

国家卫计委发布官方消息,全国11天累计报告H7N9病例35例,其中死亡7人,疫情趋于稳定。

李克强谈应对H7N9疫情:公开透明是谣言的天敌

近日,李克强总理在国务院常务会议上强调,要公开透明及时发布H7N9疫情权威信息。

H7N9又来了 专家们如是说

丝毫不曾考虑民众意愿,H7N9去冬今春又如约而至。H7N9自2013年为大众普遍认知,之后几年便从未止步。虽然北京地区并没有出现本地病例,只是收治了两例外地来京就诊的患者,但随着各地报告发病与死亡人数的不断增加,很多人恐惧情绪陡增,“谈禽色变”。近日,记者来到中国疾病预防控制中心、地坛医院等地,近距离与专家交谈,揭秘H7N9相关种种。特点:H7N9并没有那么可怕 切勿“谈禽色变”去年入冬以来,

重庆发现人感染 H7N9 病例 密切接触者未现异常

中新网重庆 3 月 7 日电重庆市卫计委 6 日深夜在其官网上通报称,重庆奉节县发现一例人感染 H7N9 病例,与其密切接触者均未出现异常。